- Home
- AQMS vs LGVN Comparison
AQMS vs LGVN Comparison
Compare AQMS & LGVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | AQMS | LGVN |
|---|---|---|
| Founded | 2014 | 2014 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Metal Fabrications | Medicinal Chemicals and Botanical Products |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 20.9M | 17.6M |
| IPO Year | 2015 | 2021 |
Fundamental Metrics
Financial Performance| Metric | AQMS | LGVN |
|---|---|---|
| Price | $5.41 | $0.55 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 1 | 2 |
| Target Price | ★ $12.00 | $6.50 |
| AVG Volume (30 Days) | 135.5K | ★ 470.2K |
| Earning Date | 11-12-2025 | 11-04-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $1,437,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $550.00 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $3.37 | $0.53 |
| 52 Week High | $39.40 | $2.24 |
Technical Indicators
Market Signals| Indicator | AQMS | LGVN |
|---|---|---|
| Relative Strength Index (RSI) | 38.29 | 35.83 |
| Support Level | $5.96 | $0.54 |
| Resistance Level | $7.61 | $0.63 |
| Average True Range (ATR) | 0.55 | 0.04 |
| MACD | -0.17 | -0.00 |
| Stochastic Oscillator | 3.19 | 8.37 |
Price Performance
Historical ComparisonAbout AQMS Aqua Metals Inc.
Aqua Metals Inc is engaged in the business of recycling Lead through a novel, proprietary and patent-pending process that it developed and named AquaRefining. The company's breakthrough, AquaRefining, delivers a product, at a higher yield, eliminates toxic waste, reduces permitting, and is less expensive to build than smelting. AquaRefining process will provide for the recycling of Lead acid batteries and the production of a pure grade Lead with a significantly lower cost of production, and with fewer environmental and regulatory issues, than conventional methods of Lead production.
About LGVN Longeveron Inc.
Longeveron Inc is a clinical-stage biotechnology company developing regenerative medicines to address unmet medical needs for specific aging-related and life-threatening conditions. Its investigational product is Lomecel-B an stem cell formulation sourced from the bone marrow of young, healthy adult donors and has potential mechanisms of action that can promote tissue repair and healing. The company currently has three pipeline indications: Hypoplastic Left Heart Syndrome (HLHS), Alzheimer's disease (AD) and Aging-related Frailty.